Nuclear Medicine
CHOLINE
Name:
Oncopet Radiofarma®
Active Principle:
18F-Fluorocholine
Therapeutic Action:
It is indicated for the initial staging of prostate cancer as well as local regional or metastatic recurrences in the case of an increase in PSA.
Nuclear Medicine
CHOLINE
Name:
Oncopet Radiofarma®
Active Principle:
18F-Fluorocholine
Therapeutic Action:
It is indicated for the initial staging of prostate cancer as well as local regional or metastatic recurrences in the case of an increase in PSA.
RELATED PRODUCTS
-
FLPET (R+D)
FLPET (R+D)It is indicated for the detection and evaluation of cell proliferation in lung, breast, colorectal, melanoma, soft tissue sarcoma and primary or metastatic brain tumors. It allows to predict the aggressiveness... -
123I MIBG BACON (R&D)
123I MIBG BACON (R&D)It is indicated for: Oncology: a) Scintigraphic localization of tumors originating in tissues that derive embryologically from the neural crest... -
131I MIBG BACON (R&D)
131I MIBG BACON (R&D)It is indicated for the diagnosis and location of neuroendocrine tumors, pheochromocytoma, medullary thyroid cancer, primary neuroblastomas and their metastases, paragangliomas and thymomas... -
PARTITION FLASK
PARTITION FLASKVial containing a mixture of solvents to carry out a chromatographic separation ... -
TECHNETIUM GENERATOR
TECHNETIUM GENERATORIt is indicated for obtaining a solution of Sodium Pertechnetate (Tc99m) ... -
IODOSOL 123I (R&D)
IODOSOL 123I (R&D)Sodium iodide (123I) solution is indicated as a diagnostic agent to evaluate thyroid function and/or morphology by scintigraphy and radioactive iodine uptake test. -
PSMA (R+D)
PSMA (R+D)It is indicated for the detection and evaluation of prostate cancer from the initial diagnosis to the monitoring of castration-resistant metastases.

